Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
-
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series
-
Ever.green Brings REI Co-op and Cutler Development Together to Support a New Solar Project in Marion County, South Carolina
-
Seaco SRL Subsidiaries Successfully Complete Consent Solicitation From Fixed Rate Note Holders
-
Transactions in connection with share buyback programme
-
Investeringsforeningen ValueInvest Danmark – Prospekt
-
SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate
-
Playboy to Repurchase 16.6 Million Shares at 28% Discount to Market Value
-
fomo Raises $75 Million Series B Led by Index Ventures To Scale Global Consumer Trading App
-
NeoVolta Confirms FEOC Compliance at Georgia Manufacturing Facility; Commissioning on Track for End of August
-
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
-
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
-
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
-
Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis
-
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
-
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
-
Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification
-
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
-
Patriot Bank Expands into Palm Beach and the South Florida Market
-
SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate
-
Saratoga Investment Corp. to Report Fiscal First Quarter 2027 Financial Results and Hold Conference Call
-
NetworkNews Audio Announces Audio Press Release (APR) Discussing AI Infrastructure Demand Creating Urgent Need for Scalable, Intelligent Automation
-
Kingstone Appoints Sylvie Widjaja to Lead California Business
-
Fengate’s 2025 Sustainability Report highlights responsible investment across housing, healthcare, digital infrastructure, and energy transition in North America
-
CaoCao Announces Full-Scale AI Transformation, Unveils RoboX Strategy to Build a Globally Leading Physical AI Mobility Technology Platform
-
Appointment of new Supervisory Board member
-
Atlantic International Reports Record First Quarter 2026 Revenue of $249.9 Million
-
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
-
Defence Construction Canada to hold 2026 Annual Public Meeting
-
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
-
Xeriant Sets Up Next Production Run of NEXBOARD™ Following Class A Fire Rating and NFPA 286 Fire Testing Certification
-
Take 5 Oil Change Opens New Location in Colorado Springs
-
Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results
-
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
-
Edmonton father of two wins $1 million after moving savings to Servus
-
Firm Capital Property Trust Announces Completion of Competition Bureau of Canada Inquiry Regarding Acquisition of 50% Interests in Ten Manufactured Home Communities for $218 Million
-
MAX Power Appoints Chad Levesque as President and New Board Director as Company Advances Toward Commercialization of Natural Hydrogen
-
Early Warning Press Release
-
Hexagon Bio Announces Formation of Clinical Advisory Board of Renowned Breast Cancer Experts to Support Development of HEX-360, a Next-Generation HER2-Targeting ADC
-
Evolve Royalties Announces DTC Eligibility
-
GoGo AI Network Inc. and Algo8 Industrial AI Inc. Announce Definitive Arrangement Agreement to Spin Out Full-Stack Industrial AI Platform to Public Markets
-
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
-
Novel Key Terms For Managing CIDP Published in Neurology® Journal
-
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of
-
GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage
-
Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.
-
Skyborne Technology, Inc (STI), a UAV Corp Company, completes initial step for Weight Balance Analysis and Flight Testing
-
MADD Canada Urges Quebecers to Celebrate Saint-Jean-Baptiste Day Responsibly
-
Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refract
-
Azure Maps Gen1 Pricing Customers To Be Migrated To Gen2 Pricing in September 2026, A 9x Cost Increase
